GA Knoll, MB Kokolo, R Mallick, A Beck… - Bmj, 2014 - bmj.com
Objective To examine risk of malignancy and death in patients with kidney transplant who receive the immunosuppressive drug sirolimus. Design Systematic review and meta …
NS Lurain, S Chou - Clinical microbiology reviews, 2010 - Am Soc Microbiol
The study of human cytomegalovirus (HCMV) antiviral drug resistance has enhanced knowledge of the virological targets and the mechanisms of antiviral activity. The currently …
RJ Baker, PB Mark, RK Patel, KK Stevens, N Palmer - BMC nephrology, 2017 - Springer
These guidelines cover the care of patients from the period following kidney transplantation until the transplant is no longer working or the patient dies. During the early phase …
J Nelson, N Alvey, L Bowman, J Schulte… - … : The Journal of …, 2022 - Wiley Online Library
Advances in maintenance immunosuppression over the past three decades have improved solid organ transplantation outcomes dramatically. Uninterrupted access to …
K Bok, KY Green - New England Journal of Medicine, 2012 - Mass Medical Soc
Norovirus Gastroenteritis in Immunocompromised Patients | New England Journal of Medicine Skip to main content The New England Journal of Medicine homepage Advanced Search …
G Martignoni, M Pea, D Reghellin, G Zamboni… - Virchows Archiv, 2008 - Springer
The perivascular epithelioid cell (PEC) is a cell type constantly present in a group of tumors called PEComas. PEC expresses myogenic and melanocytic markers, such as HMB45 and …
A Gutierrez-Dalmau, JM Campistol - Drugs, 2007 - Springer
Post-transplant malignancy is recognised as being a major limitation to the success of solid organ transplantation and it is currently considered one of the unavoidable costs of long …
The relationship between mammalian target of rapamycin complex 1 (mTORC1) signaling and muscle protein synthesis during instances of amino acid surplus in humans is based …